Table 1.
Patient Characteristics (n = 1513)
| Age in years, mean (SD) | 72.5 (12.2) |
| Gender, n (%) | |
| Male | 764 (50.5) |
| Female | 749 (49.5) |
| Primary cancer site, n (%) | |
| Upper and lower gastrointestinal tract | 421 (27.8) |
| Liver, biliary system, and pancreas | 294 (19.4) |
| Lung | 243 (16.1) |
| Urological | 115 (7.6) |
| Breast | 108 (7.1) |
| Gynecological | 94 (6.2) |
| Head and neck | 62 (4.1) |
| Hematological | 42 (2.8) |
| Others | 134 (8.9) |
| Metastasis, yes, n (%) | 1285 (84.9) |
| Chemotherapy or targeted therapy within one month, yes, n (%) | 139 (9.2) |
| ECOG PS, n (%) | |
| 0–1 | 20 (1.3) |
| 2 | 121 (8.0) |
| 3 | 700 (46.3) |
| 4 | 672 (44.4) |
| Serum levels, mean (SD) | |
| Albumin (g/dL) | 2.5 (0.7) |
| CRP (mg/dL) | 7.5 (7.3) |
| Survival time (days), median (IQR) | 20.0 (9.0–43.0) |
Values are means ± SD, median (IQR), or n (%).
CRP, C-reactive protein; ECOG PS, Eastern Cooperative Oncology Group performance status; IQR, interquartile range; SD, standard deviation.